You are about to leave the site and are being redirected to another site.

Would you like to leave this site?

Welcome To CoverOne

CoverOne® provides patient access and reimbursement support services to help patients gain appropriate access to BAVENCIO® (avelumab) in the United States.

We recognize that each patient’s situation is different and are dedicated to helping BAVENCIO patients one at a time.

Please contact us at 844-8COVER1 if your patients have any questions. To request services, please fax a completed CoverOne Enrollment Form, or enroll online through our CoverOne Enrollment Portal.

CoverOne®   

PO Box 29293
Phoenix, AZ 85038-9293

Phone: 844-8COVER1 (844-826-8371)
Fax: 1-800-214-7295
Monday-Friday, 8:00am-8:00pm Eastern Time

Reimbursement Support Program
CoverOne® will help you and your patients understand the specific coverage and reimbursement guidelines for BAVENCIO® (avelumab) and provide relevant billing and coding information.
Patient Assistance Support Program
CoverOne includes a patient assistance program that provides BAVENCIO® (avelumab) at no charge for patients who meet certain income, insurance (ie, uninsured), and residency eligibility criteria.
Co-pay Assistance Support Program
CoverOne provides co-pay assistance for privately-insured BAVENCIO® (avelumab) patients with co-pay/co-insurance responsibilities who meet the program eligibility criteria.

TERMS OF USE     PRIVACY POLICY     CONTACT US     SITE MAP    

US/AVE/0317/0160b(1)a     May 2019
© 2019 EMD Serono

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch, or call 1-800-FDA-1088. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.